Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Sunshine Biopharma, Inc
| Metric | Sunshine Biopharma, Inc SBFM, SBFMWOther |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $36M |
| Net income (latest) | −$6M |
| Operating margin | −17.2% |
| Net margin | −16.5% |
| Return on equity | −25.9% |
| Return on assets | −19.9% |
| Return on capital (ROCE) | −26.3% |
| Debt / equity | 0.31× |
| Revenue growth (YoY) | 4.1% |
| Altman Z″ (distress) | -1.63 |
| Accruals / assets | −2.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.